SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 196 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,359,000 | -30.8% | 354,276 | -54.5% | 0.01% | -35.7% |
| Q3 2017 | $9,193,000 | -13.4% | 779,071 | -23.0% | 0.01% | -26.3% |
| Q2 2017 | $10,621,000 | -33.1% | 1,011,477 | -29.9% | 0.02% | -34.5% |
| Q1 2017 | $15,878,000 | +26.9% | 1,443,435 | +56.3% | 0.03% | +11.5% |
| Q4 2016 | $12,517,000 | +54.6% | 923,794 | +40.5% | 0.03% | +85.7% |
| Q3 2016 | $8,096,000 | +73.0% | 657,680 | +54.2% | 0.01% | +27.3% |
| Q2 2016 | $4,679,000 | +144.2% | 426,527 | +143.3% | 0.01% | +120.0% |
| Q1 2016 | $1,916,000 | +49.8% | 175,317 | +136.9% | 0.01% | +66.7% |
| Q4 2015 | $1,279,000 | -69.5% | 73,998 | -65.0% | 0.00% | -62.5% |
| Q3 2015 | $4,199,000 | -48.1% | 211,341 | -57.0% | 0.01% | -46.7% |
| Q2 2015 | $8,083,000 | -35.5% | 491,983 | -38.9% | 0.02% | -34.8% |
| Q1 2015 | $12,526,000 | -6.8% | 804,994 | -14.5% | 0.02% | -17.9% |
| Q4 2014 | $13,439,000 | +476.5% | 941,101 | +162.4% | 0.03% | +366.7% |
| Q3 2014 | $2,331,000 | +12.7% | 358,679 | +19.6% | 0.01% | 0.0% |
| Q2 2014 | $2,069,000 | -33.8% | 299,819 | -31.4% | 0.01% | -33.3% |
| Q1 2014 | $3,127,000 | +206.3% | 437,368 | +302.5% | 0.01% | +200.0% |
| Q4 2013 | $1,021,000 | +217.1% | 108,669 | +110.4% | 0.00% | +200.0% |
| Q3 2013 | $322,000 | -17.4% | 51,645 | -12.8% | 0.00% | 0.0% |
| Q2 2013 | $390,000 | – | 59,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|